NCT Number: NCT00366665
Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems
To compare the efficiency of the Infiniti vision system and the Series 20000 Legacy System phacoemulsification units during routine cataract extraction.
Looking for future studies?
Notify MeKey information
Conditions
Age range
50 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Cataract
- Eligible for cataract extraction with primary implantation of a posterior chamber IOL
- 2 to 3+ cataract density
Exclusion criteria
- Preoperative ocular pathology that can affect visual acuity
- Corneal irregularities such as keratoconus, corneal dystrophy, corneal opacities.
- Previous intraocular or corneal surgery.
- Other ocular surgery at the time of the cataract extraction.
- Surgical Exclusion Criteria:
- Significant intraoperative intraocular bleeding
- Detached Descemet's membrane
- Implantation of the intraocular lens in the anterior chamber or sulcus
Treatment and study plan
Infinit system
DevicePrimary outcomes
-
Ultrasound time
-
Amount of fluid used
-
Post operative visual acuity.
Sponsors and collaborators
Lead sponsor
Medical University of South Carolina
Other
Registry information
Official study title
Comparison of the Infiniti Vision and the Series 20000 Legacy Systems
Important dates
- Study start
- 2005
- Study completion
- 2005
- First posted
- Aug 21, 2006
- Registry last updated
- Aug 21, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Cerebral Oxymeter and End Tidal Carbondioxide Values Under Surgical Drapes With and Without Past COVID-19 Infection
NCT05571683
Anesthesia, Local, Cataract Extraction
Düzce, Turkey (Türkiye)
View Trial DetailsA Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00
NCT03364972
Behavior, Cataract
London, United Kingdom
View Trial DetailsClinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction
NCT02973880
Cataract, Cataract Extraction
Potsdam, Germany
View Trial DetailsComparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation
NCT00366691
Cataract, Cataract Extraction
Charleston, South Carolina, United States
View Trial Details